Cargando…
Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
Exosomes are naturally occurring nanosized particles that aid intercellular communication by transmitting biological information between cells. Exosomes have therapeutic efficacy that can transfer their contents between cells as natural carriers. In addition, the exosomal contents delivered to the r...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580186/ https://www.ncbi.nlm.nih.gov/pubmed/36258195 http://dx.doi.org/10.1186/s12935-022-02743-3 |
_version_ | 1784812336791420928 |
---|---|
author | Hussen, Bashdar Mahmud Faraj, Goran Sedeeq Hama Rasul, Mohammad Fatih Hidayat, Hazha Jamal Salihi, Abbas Baniahmad, Aria Taheri, Mohammad Ghafouri-Frad, Soudeh |
author_facet | Hussen, Bashdar Mahmud Faraj, Goran Sedeeq Hama Rasul, Mohammad Fatih Hidayat, Hazha Jamal Salihi, Abbas Baniahmad, Aria Taheri, Mohammad Ghafouri-Frad, Soudeh |
author_sort | Hussen, Bashdar Mahmud |
collection | PubMed |
description | Exosomes are naturally occurring nanosized particles that aid intercellular communication by transmitting biological information between cells. Exosomes have therapeutic efficacy that can transfer their contents between cells as natural carriers. In addition, the exosomal contents delivered to the recipient pathological cells significantly inhibit cancer progression. However, exosome-based tumor treatments are inadequately precise or successful, and various challenges should be adequately overcome. Here, we discuss the significant challenges that exosomes face as drug carriers used for therapeutic targets and strategies for overcoming these challenges in order to promote this new incoming drug carrier further and improve future clinical outcomes. We also present techniques for overcoming these challenges. |
format | Online Article Text |
id | pubmed-9580186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95801862022-10-20 Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy Hussen, Bashdar Mahmud Faraj, Goran Sedeeq Hama Rasul, Mohammad Fatih Hidayat, Hazha Jamal Salihi, Abbas Baniahmad, Aria Taheri, Mohammad Ghafouri-Frad, Soudeh Cancer Cell Int Review Exosomes are naturally occurring nanosized particles that aid intercellular communication by transmitting biological information between cells. Exosomes have therapeutic efficacy that can transfer their contents between cells as natural carriers. In addition, the exosomal contents delivered to the recipient pathological cells significantly inhibit cancer progression. However, exosome-based tumor treatments are inadequately precise or successful, and various challenges should be adequately overcome. Here, we discuss the significant challenges that exosomes face as drug carriers used for therapeutic targets and strategies for overcoming these challenges in order to promote this new incoming drug carrier further and improve future clinical outcomes. We also present techniques for overcoming these challenges. BioMed Central 2022-10-18 /pmc/articles/PMC9580186/ /pubmed/36258195 http://dx.doi.org/10.1186/s12935-022-02743-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Hussen, Bashdar Mahmud Faraj, Goran Sedeeq Hama Rasul, Mohammad Fatih Hidayat, Hazha Jamal Salihi, Abbas Baniahmad, Aria Taheri, Mohammad Ghafouri-Frad, Soudeh Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy |
title | Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy |
title_full | Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy |
title_fullStr | Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy |
title_full_unstemmed | Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy |
title_short | Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy |
title_sort | strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580186/ https://www.ncbi.nlm.nih.gov/pubmed/36258195 http://dx.doi.org/10.1186/s12935-022-02743-3 |
work_keys_str_mv | AT hussenbashdarmahmud strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy AT farajgoransedeeqhama strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy AT rasulmohammadfatih strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy AT hidayathazhajamal strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy AT salihiabbas strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy AT baniahmadaria strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy AT taherimohammad strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy AT ghafourifradsoudeh strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy |